Showing results (41-50 of 366) with videos related to
Sort By:
Pageof 37
Seminars in Oncology|November 13, 2003
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancerMelody A Cobleigh, Virginia K Langmuir, George W Sledge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
A physiologic imaging pilot study of breast cancer treated with AZD2171Kathy D Miller, Michael Miller, Sanjana Mehrotra, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analoguesXiangshu Fei, Qi-Huang Zheng, Ji-Quan Wang, et al.Oncology (Williston Park, N.Y.)|April 1, 2006
Twenty years of systemic therapy for breast cancerLida Mina, George W SledgeCancer Journal (Sudbury, Mass.)|July 30, 2015
Targeted Therapy for Cancer in the Genomic EraAnosheh Afghahi, George W SledgeBreast Cancer Research and Treatment|June 25, 2017
Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?Ann H Partridge, Karen Sepucha, Anne O'Neill, et al.Breast Cancer Research and Treatment|February 5, 2005
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery LaboratoryKathy D Miller, Sharon E Soule, Cynthia Calley, et al.Nature Reviews. Clinical Oncology|April 20, 2011
Rethinking the metastatic cascade as a therapeutic targetLida A Mina, George W SledgeOncology (Williston Park, N.Y.)|September 17, 2014
Heterogeneity and cancerKimberly H Allison, George W SledgeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
"Vertical" Inhibition of HER2 Yields Horizontal Gains in the ClinicGeorge W Sledge, Mark D PegramPageof 37